Oramed Pharmaceuticals (ORMP) Accumulated Expenses (2018 - 2026)
Oramed Pharmaceuticals (ORMP) posted Accumulated Expenses of $475000.0 for Q1 2026, down 56.18% on a QoQ basis from $1.1 million in Q4 2025, and up 166.85% year-over-year from $178000.0 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Accumulated Expenses (2018 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Accumulated Expenses history runs 9 years deep, the most recent figure standing at $475000.0 for Q1 2026.
- Quarterly Accumulated Expenses rose 166.85% year-over-year to $475000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $475000.0 (up 166.85% YoY) and the FY2025 annual result came in at $1.1 million, up 169.65% from the prior year.
- Accumulated Expenses was $475000.0 for Q1 2026 at Oramed Pharmaceuticals, down from $1.1 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $1.1 million in Q4 2025 and bottomed at $21000.0 in Q4 2022.
- A 5-year average of $288461.5 and a median of $178000.0 in 2025 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Accumulated Expenses surged 2780.95% — and 2024, when it plunged 33.55%.
- Oramed Pharmaceuticals' Accumulated Expenses stood at $21000.0 in 2022, then jumped by 2780.95% to $605000.0 in 2023, then plunged by 33.55% to $402000.0 in 2024, then jumped by 169.65% to $1.1 million in 2025, then tumbled by 56.18% to $475000.0 in 2026.
- Business Quant data shows ORMP's Accumulated Expenses at $475000.0 in Q1 2026, $1.1 million in Q4 2025, and $585000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 475,000.00 |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 585,000.00 |
| Jun 30, 2025 | 259,000.00 |
| Mar 31, 2025 | 178,000.00 |
| Dec 31, 2024 | 402,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 29,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | 605,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Jun 30, 2023 | 27,000.00 |
| Dec 31, 2022 | 21,000.00 |
| Aug 31, 2021 | 1.24 Mn |
| Aug 31, 2020 | 54,000.00 |
| Aug 31, 2019 | 25,000.00 |
| Aug 31, 2018 | 80,000.00 |